The Wolverine project aims to research therapies for Hereditary Optical Neuropathies (NOH) such as Wolfram Syndrome (Neuro-Degenerative Disease). INSERM discovered the first biomarker of this disease (the WFS1 partner protein). Thus the objective of this project is to validate this biomarker, while developing research on gene therapy ocular but also systemic.